St. Petersburg International ForumPharmacy. Medical Equipment. Biotechnology                                              ...
IPhEB St. Petersburg International ForumSt. Petersburg International Forum IPhEB is the key event in Russia,dedicated to s...
Aims of the Forum:• To intensify contacts and experience exchange between the major  players of the market: heads and expe...
Forum IPhEB 2012 is a multi-focused  business-oriented event with the following structure:• Business programme in pharmacy...
With the support of:•   The Ministry of Industry and Trade of the Russian Federation;•   The Chamber of Commerce and Indus...
Target audience of the IPhEB 2012:•   The leading companies of medical     Manufacture of pharmaceuticals, chemical and ph...
The Outcomes of the IPhEB-2012 ForumIPhEB International Forum on pharmacy, medical industry and biotechnology wassuccessfu...
The Forum business programme consisted of 13 topicalsessions and master classes on innovative development       of pharmac...
The plenary sessionThe plenary session National prioritiesin       pharmaceutical         industrydevelopment, held on the...
Sergey Tsyb, Director of department for chemical and technological   complex and bio-engineering technologies of the Minis...
Panel discussion: Optimisation of pricing strategy for vital and     essential medicines: search for effective tools for s...
Round table Promotion of R&D in the sphere of pharmacy                 and biotechnologyThe round table attracted special ...
Topical session International and regional cooperation in         the field of pharmacy and biotechnologyAt the topical se...
IPhEB award in the sphere of pharmacy and biotechnology    It is for the first time that anIPhEB award in the sphere ofpha...
IPhEB award in the sphere of pharmacy and biotechnologyBiocad with its product Genferone Light Spray became the winner in ...
Business Matchmaking Center          For three working days of Business          Matchmaking Center – a communication site...
Exhibition of Medical Pharmaceutical and Laboratory Equipment                       within the frameworks of IPhEB ForumAn...
Exhibition of Medical Pharmaceutical and Laboratory EquipmentThe exhibition was participated by thelargest    Russian     ...
Federal Service on Surveillance in Healthcare and Social Development         of the Russian Federation for medicines quali...
Testimonials   On the whole, as participants of the business programme andexhibition exposition noted, the IPhEB Forum was...
TestimonialsRobert Rosen, Director General of Selecta(RUS) Company, Bind (RUS):‘It was a very interesting Forum. Such anev...
TestimonialsMartin Schloh, Advisory in the sphere ofpharmacy and biotechnology atPricewaterhouseCoopers:“I would like to t...
TestimonialsSergey Smirnov, Board Chairman of Novo Nordisk LLC:“St. Petersburg International Forum IPhEB left a veryfavour...
St. Petersburg International Forum                                 Pharmacy engineering                                 Me...
The structure of the IPhEB -2013                     St. Petersburg International Pharmacy Engineering and                ...
St. Petersburg International Forum                    Pharmacy engineering                    Medical equipment           ...
Upcoming SlideShare
Loading in …5
×

IPhEB 2012 outcomes

781 views

Published on

Published in: Business
  • Be the first to comment

  • Be the first to like this

IPhEB 2012 outcomes

  1. 1. St. Petersburg International ForumPharmacy. Medical Equipment. Biotechnology THE OUTCOMESSt. PetersburgApril 25-27, 2012
  2. 2. IPhEB St. Petersburg International ForumSt. Petersburg International Forum IPhEB is the key event in Russia,dedicated to strategic issues of innovative development ofpharmaceutical, biotechnological and medical industry.The IPhEB 2012 Forum became one of the largest Russian events in thescientific, technical and innovations sphere. The event was mainly focusedon elaboration of effective solutions for rapid development of Russianpharmacy and medicine, creation, production and introduction ofinnovative, high quality medications into clinical practice in order topromote realization of state and private initiatives for development ofthis extremely important sphere. 2
  3. 3. Aims of the Forum:• To intensify contacts and experience exchange between the major players of the market: heads and experts of companies manufacturing medical or pharmaceutical products, R&D centers, health care facilities; investment, financial and service companies;• To attract investments to the market; tools and mechanisms of dynamic innovative development;• To introduce innovative technologies;• To promote locally-manufactured products in international markets 3
  4. 4. Forum IPhEB 2012 is a multi-focused business-oriented event with the following structure:• Business programme in pharmacy, medicine and biotechnology.• Exhibition of medical, pharmaceutical and laboratory equipment and technology.• The tour to Federal Service on Surveillance in Healthcare and Social Development of the Russian Federation for medicines quality control.• Marchmaking Center• “Presentation zone” for innovative developments• IPhEB Awards ceremony in nominations: Business project of the year, Product of the year, IPhEB Science. 4
  5. 5. With the support of:• The Ministry of Industry and Trade of the Russian Federation;• The Chamber of Commerce and Industry of the Russian Federation;• Plenipotentiary Representation of the President of the Russian Federation in the North- Western Federal District;• St. Petersburg City AdministrationThe Forum has gathered heads of executive authorities of all levels, rectors of the largestdomestic higher educational institutions and research centers, top managers and experts ofpharmacy companies, including MSD, Novartis, Novo-Nordisk, Stada, Philips, AstraZenecaand others. 5
  6. 6. Target audience of the IPhEB 2012:• The leading companies of medical Manufacture of pharmaceuticals, chemical and pharmaceutical industry and pharmaceutical industry; Health facilities Production and delivery of medical, pharmaceutical, laboratory, diagnostic and analytical• The largest R&D institutions; equipment R&D• Relevant sector committees; Pharmacies• Investors, financial institutions, Education investment and insurance Financial institutions, investments (banks, venture funds, etc.) Other companies;• Representatives of state power . 9% 4% 17% 6% 14% 23% 7% 20% 6
  7. 7. The Outcomes of the IPhEB-2012 ForumIPhEB International Forum on pharmacy, medical industry and biotechnology wassuccessfully held in St. Petersburg, having gathered over 1,000 participants: heads of federaland regional authorities, defining the industry development policy, the largest highereducational institutions and research centers of the country, as well as companies from 18regions of Russia and 15 countries.Promotion of development of the pharmaceutical cluster in St. Petersburg;Expert discussion of the development prospects in the pharmaceutical sector among morethan 1 000 participants;Attraction of investment to the development of the pharmaceutical cluster; 7
  8. 8. The Forum business programme consisted of 13 topicalsessions and master classes on innovative development of pharmaceutical and medical industry. 8
  9. 9. The plenary sessionThe plenary session National prioritiesin pharmaceutical industrydevelopment, held on the second day ofthe Forum, was opened by GeorgyPoltavchenko, St. Petersburg Governor:“I am glad to welcome the participants ofthe International Forum which is thebest site to discuss the issues ofdomestic pharmacy industrydevelopment. This site createsfavourable conditions for a dialoguebetween pharmacists, business andauthorities’. Georgy Poltavchenkostressed that pharmacy is not only aboutbusiness, but also about work for thesake of human well-being. 9
  10. 10. Sergey Tsyb, Director of department for chemical and technological complex and bio-engineering technologies of the Ministry of Industry and Trade of the Russian FederationSergey Tsyb in his speech summed up intermediate results ofimplementing the federal target programme ‘Development Strategyfor Pharmaceutical and medical industry of the Russian Federationfor the period until 2020 and further outlook’ as one of the mosteffective tools for complex industry transformation:“St. Petersburg is demonstrating significant rates in terms ofinnovative development of pharmacy and medical industry.Attractive investment conditions have been created in the region.The city itself – our northern capital – traditionally possesses themost important resource for such a science-intensive industry asmedicine, namely it has human capital. Much has been done and isstill being done for the successful formation of one of the firstinnovative medical and pharmaceutical clusters in Russia, whichpresupposes the increase in shares of domestic pharmacy products,improvement of their competitiveness and export opportunities.Thus, the region has all prerequisites for successful implementationof projects designed to create pharmaceutical enterprises as well asresearch and development centers within the framework of thePHARMA 2020 strategy”. 10
  11. 11. Panel discussion: Optimisation of pricing strategy for vital and essential medicines: search for effective tools for sustainable development of the Russian pharmaceutical marketDuring panel discussion, Dmitry Ter-Stepanov, Head of Department for CompetitionDevelopment, Ministry for Economic, Development of the Russian Federation, delivered aspeech. He informed that an inter-institutional group has been created which is intended toelaborate price calculation method for new medications under supervision of DeputyMinister Mikhail Oseevsky. According to his words, ‘current methods have become outdatedand if we keep using them, it may result in erosion of the whole medications groups from themarket, mainly the cheap ones, and the fact that the manufacturer has no opportunity to re-register the price leads to the polymorphism in drugs (even the smallest change in the nameof pharmaceuticals by adding another definition or a slight replacement of the preparationcomponents allows to register a new price). 11
  12. 12. Round table Promotion of R&D in the sphere of pharmacy and biotechnologyThe round table attracted special attentionof the participants. Moderator VitalyPrutskiy, Head of R&D Information inRussia and Eastern Europe, Head of Centrefor bio-informatics and predictive medicinein St. Petersburg, set an active tempo to thediscussion, having told how quickly – “ittook AstraZeneca less than a year” – thecompany managed to open a Center in St.Petersburg, which will solve no onlyregional tasks but also will serve the wholeworld using local resources. Participants ofthis round table focused their attention onthe opportunities and ambitions of RussianR&D market. 12
  13. 13. Topical session International and regional cooperation in the field of pharmacy and biotechnologyAt the topical session, held on the secondday of the Forum, Zakhar Golant, DeputyChairman of Committee for EconomicDevelopment, Industrial Policy and Tradeof St. Petersburg Government, emphasizedthat the improvement of internationalcooperation is necessary to develop thewhole region, therefore the Northerncapital attaches great importance to thehigh quality meetings and events industry. 13
  14. 14. IPhEB award in the sphere of pharmacy and biotechnology It is for the first time that anIPhEB award in the sphere ofpharmacy and biotechnology wasestablished with the aim topromote development of the latestachievements in the sphere ofpharmaceutical, biotechnologicaland medical technologies. The awarding ceremony and congratulations to the laureates took place during gala reception on behalf of Georgy Poltavchenko, St. Petersburg Governor on the occasion of the Forum Opening. 14
  15. 15. IPhEB award in the sphere of pharmacy and biotechnologyBiocad with its product Genferone Light Spray became the winner in Product ofthe year nomination. Dmitry Morozov, Chairman of the Board of Directorsreceived the award.The nomination for Business project of the year was awarded to the Center ofprotone radiation therapy of the Center of nuclear medicine at theInternational Institute of Biologic Systems named after S.M. Berezin. Theaward was handed to Georgy Andreev, Chief Medical Physicist of the company.The center implements modern methods of nuclear medicine in clinical treatmentpractice, prolongs lives of oncological patients as well.IPhEB Science, a special personal award was honoured to Elena Shpakova – asecond year graduate student of RAS Institue of High-Molecular Compounds, forthe best work in the ‘Chemical synthesis of biologically active substances’ section. 15
  16. 16. Business Matchmaking Center For three working days of Business Matchmaking Center – a communication site designed to establish new business and partnership contacts – over 70 meetings were registered. The most significant negotiations were: a meeting of representative of India Ministry of pharmaceutical industry, the administration of the UBM company (Great Britain) and Zakhar Golant, Deputy Chairman of Committee for Economic Development, Industrial Policy and Trade, as well as the meeting of FinnMedi company representatives with Alexander Iova, Head of the Chair of Neurology and Neurosurgery at the Medical Academy of Post-Graduate Education. The Business Matchmaking Center became the major link between the Forum participants and the exhibitors. 16
  17. 17. Exhibition of Medical Pharmaceutical and Laboratory Equipment within the frameworks of IPhEB ForumAnother novelty of the Forum is the Exhibition of Medical Pharmaceutical and LaboratoryEquipment within the frameworks of IPhEB Forum, representing the latest achievements,products and services in the sphere of medical, pharmaceutical and biotechnologicalindustry. 17
  18. 18. Exhibition of Medical Pharmaceutical and Laboratory EquipmentThe exhibition was participated by thelargest Russian and foreigncompanies, including PHARMEXCIL(India), Favea, Khimexpert, SartoriusIRC and others. A separate expositionwas formed by the companies,members of St. Petersburgpharmaceutical and medical industrycluster – Novartis, MSDPharmaceuticals, Polysan, Samson-Med, Geropharm, LDC MIBS(Treatment and Diagnostics Center ofInternational Institute for Biologicalsystems) and NP Medical and‘Pharmaceutical Projects. XXI century’. 18
  19. 19. Federal Service on Surveillance in Healthcare and Social Development of the Russian Federation for medicines quality control.A specialised tour took place within the frameworks of the business programme – the IPhEBForum participants visited a new Federal Service on Surveillance in Healthcare and SocialDevelopment of the Russian Federation for medicines quality control.It is located in the four-storey building and occupies total area of 2,700 sq.m. Theparticipants of this tour observed organisational department, analytical, microbiological andpharmacological laboratories, where 48 high-grade experts work.“You will not find such a laboratory anywhere in the city. Unique people work here”, ElenaTelnova, acting as head of Roszdravnadzor, assures, “there are only three laboratories ofsuch a high level in Russia: in Gudermes, Rostov-on-Don and Krasnoyarsk”. The plans includeopening of laboratories in Moscow and other cities. Within the nearest time, a mobileexpress-laboratory on the basis of St. Petersburg laboratory complex for medicines qualitycontrol will start working directly on the inspection facility: pharmacies, drugstores,hospitals, clinics. 19
  20. 20. Testimonials On the whole, as participants of the business programme andexhibition exposition noted, the IPhEB Forum was held successfully. Tatiana Mamaeva, Head of Regulatory Department, National Center of Expertise for Phramaceutical Products of the Republic of Kazakhstan, “I came from Kazakhstan to visit the Forum for the first time. I have great impressions from organisation, discussions and topics. It is undoubtedly an interesting and necessary event. The most currently important topics of the modern pharmaceutical industry, exciting for the specialists of all countries were discussed here. It is a real platform for a dialogue. I wish I could visit all the Forum events”. 20
  21. 21. TestimonialsRobert Rosen, Director General of Selecta(RUS) Company, Bind (RUS):‘It was a very interesting Forum. Such anevent contributes a lot to the futuredevelopment of science. The Forum lets usunderstand and find one’s niche, findresearch and administrative resources. TheForum provides all the opportunities forfuture successful work. Success comes withclear purposes’. 21
  22. 22. TestimonialsMartin Schloh, Advisory in the sphere ofpharmacy and biotechnology atPricewaterhouseCoopers:“I would like to thank all event participants andorganisers. Special thanks to the Foruminterpreters. I saw energy and light in theparticipants’ eyes’. 22
  23. 23. TestimonialsSergey Smirnov, Board Chairman of Novo Nordisk LLC:“St. Petersburg International Forum IPhEB left a veryfavourable impression by its scale, organisation level,number of participants and topics under discussion. Ilearned a lot of useful information. A wonderful paneldiscussion has just finished, where I made a report. Andyesterday a plenary session took place, where GeorgyPoltavchenko, St. Petersburg Governor, Sergey Tsyb,Director of Department for chemical and technologicalcomplex and bio-engineering technologies of the Ministry of Industry andTrade of the Russian Federation, Elena Telnova, Deputy Head of FederalService for Supervision of Healthcare and Social Development took part.Participation of such high officials also proves the Forum significance for theRussian pharmacy and biotechnology”. 23
  24. 24. St. Petersburg International Forum Pharmacy engineering Medical equipment Radiology BiotechnologySt. PetersburgApril 10-11, 2013 24
  25. 25. The structure of the IPhEB -2013 St. Petersburg International Pharmacy Engineering and Biotechnology Forum International Medical Congress IMedR International conference for medical radiologyExhibition of pharmaceutical andlaboratory equipment and technologyExhibition of medical equipment andtechnics 25
  26. 26. St. Petersburg International Forum Pharmacy engineering Medical equipment Radiology BiotechnologySt. PetersburgApril 10-11, 2013

×